Dr. Christiane Schönfeld

Scientific Coordinator

​

Christiane studied Biology and Molecular Biotechnology in Rheinbach and Bonn. After obtaining her Master's Degree, she joined Prof. Winfried Wels' lab at the Georg-Speyer-Haus in Frankfurt/Main. In her PhD thesis she worked on the generation of tumour-specific natural killer cells for adoptive cancer immunotherapy. As a postdoctoral researcher she joined Prof. Dr. Robert Dinser's lab at the Kerckhoff Clinic in Bad Nauheim. In a collaboration project with the Max-Planck-Institute for Heart and Lung Research she worked on the identification of key players involved in knee joint regeneration in the red-spotted newt. Christiane joined the group in November 2017 and works as scientific coordinator. She has two children (born 2013 and 2016).

  

EXPERIENCE

  

11/2017 - present      Scientific Coordinator in Prof. Rajalingam's Group 

 

09/2011 - 08/2016     PostDoc at the Kerckhoff Clinic, Bad Nauheim

​

03/2011 - 08/2011     PostDoc at the Georg-Speyer-Haus, Frankfurt/Main

​

EDUCATION

​

11/2006 - 03/2011    PhD student at the Georg-Speyer-Haus, Frankfurt/Main

​

10/2004 - 09/2006    Master Molecular Biotechnology, University of Bonn

 

10/2001 - 09/2004    Bachelor in Biology, University of Applied Sciences Bonn-Rhein-Sieg

 

PUBLICATIONS​

​

• Tavri S, Jha P, Meier R, Henning TD, Müller T, Hostetter D, Knopp C, Johansson M, Reinhart V, Boddington S, Sista A, Wels WS, Daldrup-Link HE. (2009) Optical imaging of cellular immunotherapy against prostate cancer. Mol Imaging 8: 15-26.

• ​

• Jha P, Reinhart V, Knopp C, Li S, Wels WS, Wendland M, Daldrup-Link H. (2010) NK-cell tracking using non invasive imaging techniques; in: Natural Killer Cells. Editor: Lotze M, Thomson A, 653-664, Elsevier, San Diego.

•  

• Meier R, Golovko D, Tavri S, Henning TD, Knopp C, Piontek G, Rudelius M, Heinrich P, Wels WS, Daldrup-Link H. (2011) Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging. Magn Reson Med. 65: 756-763.

•  

• Sahm C, Schönfeld K, Wels WS. (2012) Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor. Cancer Immunol Immunother. 61:1451-61.

•  

• Schönfeld K, Sahm C, Zhang C, Naundorf S, Brendel C, Odendahl M, Nowakowska P, Bönig H, Köhl U, Kloess S, Köhler S, Holtgreve-Grez H, Jauch A, Schmidt M, Schubert R, Kühlcke K, Seifried E, Klingemann HG, Rieger MA, Tonn T, Grez M, Wels WS. (2015) Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor. Mol Ther. 23:330-38.

•  

• Schönfeld C, Pap T, Neumann E, Müller-Ladner U. (2015) Fibroblasts as pathogenic cells in rheumatic inflammaton. Z Rheumatol. 74: 33-38

​​